How does IVQ.U's PS Ratio compare to its peers?

IVQ.U is good value based on its Price-To-Sales Ratio (0x) compared to the peer average (2.5x).

How does IVQ.U's PS Ratio compare vs other companies in the CA Real Estate Industry?

IVQ.U is good value based on its Price-To-Sales Ratio (0x) compared to the Canadian Real Estate industry average (2.7x).

What is IVQ.U's PS Ratio compared to its Fair PS Ratio? This is the expected PS Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

Insufficient data to calculate IVQ.U's Price-To-Sales Fair Ratio for valuation analysis.

What is the Fair Price of IVQ.U when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

IVQ.U ($0.08) is trading below our estimate of [[fair value]] ($0.39)

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

Insufficient data to show price forecast.

Invesque (TSX:IVQ.U) - Stock Price, News & Analysis

IVQ.U Stock Overview

Operates as a health care real estate company in North America. More details

IVQ.U fundamental analysis
Snowflake Score
Valuation	4/6
Future Growth	0/6
Past Performance	0/6
Financial Health	3/6
Dividends	0/6

Rewards

Trading at 79.4% below our estimate of its fair value

Earnings have grown 4% per year over the past 5 years

Risk Analysis

Does not have a meaningful market cap ($6M)

Highly volatile share price over the past 3 months compared to the Canadian market

Invesque Inc. Competitors

Realia Properties

TSXV:RLP

CA$5.1m

Gulf & Pacific Equities

TSXV:GUF

CA$9.6m

Regent Pacific Properties

TSXV:RPP

CA$2.6m

Tempus Capital

CNSX:TEMP

CA$2.6m

Price History & Performance

Summary of all time highs, changes and price drops for Invesque
Historical stock prices
Current Share Price	CA$0.08
52 Week High	CA$0.36
52 Week Low	CA$0.055
Beta	1.42
11 Month Change	-15.79%
3 Month Change	-50.00%
1 Year Change	-65.22%
33 Year Change	-95.21%
5 Year Change	-98.77%
Change since IPO	-99.12%

Recent updates

Shareholder Returns

	IVQ.U	CA Real Estate	CA Market
7D	6.7%	0.9%	2.2%
1Y	-65.2%	29.5%	23.4%

Return vs Industry: IVQ.U underperformed the Canadian Real Estate industry which returned 29.5% over the past year.

Return vs Market: IVQ.U underperformed the Canadian Market which returned 23.4% over the past year.

Price Volatility

Is IVQ.U's price volatile compared to industry and market?
IVQ.U volatility
IVQ.U Average Weekly Movement	20.0%
Real Estate Industry Average Movement	4.8%
Market Average Movement	8.3%
10% most volatile stocks in CA Market	17.7%
10% least volatile stocks in CA Market	2.9%

Stable Share Price: IVQ.U's share price has been volatile over the past 3 months compared to the Canadian market.

Volatility Over Time: IVQ.U's weekly volatility (20%) has been stable over the past year, but is still higher than 75% of Canadian stocks.

About the Company

Founded	Employees	CEO	Website
2007	1,766	Adlai Chester	invesque.com

Invesque Inc. operates as a health care real estate company in North America. The company's investment property portfolio includes investments in independent living, assisted living, memory care, skilled nursing, and transitional care properties. It also includes investments in owner occupied seniors housing properties, including the ownership of real estate properties, as well as provides management services.

Invesque Inc. Fundamentals Summary

How do Invesque's earnings and revenue compare to its market cap?
IVQ.U fundamental statistics
Market cap	US$4.22m
Earnings (TTM)	-US$61.85m
Revenue (TTM)	US$176.68m

0.0x

P/S Ratio

-0.1x

P/E Ratio

Is IVQ.U overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
IVQ.U income statement (TTM)
Revenue	US$176.68m
Cost of Revenue	US$121.62m
Gross Profit	US$55.07m
Other Expenses	US$116.91m
Earnings	-US$61.85m

Last Reported Earnings

Sep 30, 2024

Next Earnings Date

n/a

Earnings per share (EPS)	-1.10
Gross Margin	31.17%
Net Profit Margin	-35.01%
Debt/Equity Ratio	408.8%

How did IVQ.U perform over the long term?

See historical performance and comparison

IVQ.U Stock Overview

Rewards

Risk Analysis

Invesque Inc. Competitors

TSXV:RLP

CA$5.1m

TSXV:GUF

CA$9.6m

TSXV:RPP

CA$2.6m

CNSX:TEMP

CA$2.6m

Price History & Performance

Recent News & Updates

Third quarter 2024 earnings released: US$0.13 loss per share (vs US$0.013 profit in 3Q 2023)

Invesque Inc. Reports Impairment Charges for the Third Quarter Ended September 30, 2024

Insufficient new directors

Second quarter 2024 earnings released: US$0.27 loss per share (vs US$0.81 loss in 2Q 2023)

An undisclosed buyer acquired skilled nursing facility in Wisconsin from Invesque Inc. (TSX:IVQ) for $5060.

New major risk - Market cap size

Recent updates

Third quarter 2024 earnings released: US$0.13 loss per share (vs US$0.013 profit in 3Q 2023)

Invesque Inc. Reports Impairment Charges for the Third Quarter Ended September 30, 2024

Insufficient new directors

Second quarter 2024 earnings released: US$0.27 loss per share (vs US$0.81 loss in 2Q 2023)

An undisclosed buyer acquired skilled nursing facility in Wisconsin from Invesque Inc. (TSX:IVQ) for $5060.

New major risk - Market cap size

First quarter 2024 earnings released: US$0.10 loss per share (vs US$0.19 loss in 1Q 2023)

Invesque Inc. Announces Chief Executive Officer Changes, Effective May 10, 2024

Now 36% undervalued after recent price drop

Invesque Inc., Annual General Meeting, Jun 20, 2024

Now 21% undervalued

Full year 2023 earnings released: US$1.59 loss per share (vs US$0.74 loss in FY 2022)

Invesque Inc. Reports Impairment of Property, Plant and Equipment for the Fourth Quarter Ended December 31, 2023

Now 22% undervalued

Now 43% undervalued after recent price drop

Third quarter 2023 earnings released: EPS: US$0.01 (vs US$0.22 loss in 3Q 2022)

Price target decreased by 12% to US$1.53

Now 28% undervalued after recent price drop

Now 22% undervalued after recent price drop

Second quarter 2023 earnings released: US$0.82 loss per share (vs US$0.16 loss in 2Q 2022)

Invesque Inc. to Report Q2, 2023 Results on Aug 14, 2023

Invesque Inc. Announces Chief Financial Officer Changes

Price target increased by 12% to US$1.83

First quarter 2023 earnings released: US$0.19 loss per share (vs US$0.10 profit in 1Q 2022)

Price target increased by 12% to US$1.83

Full year 2022 earnings released: US$0.74 loss per share (vs US$0.22 loss in FY 2021)

Price target decreased by 9.3% to US$1.63

Third quarter 2022 earnings released: US$0.24 loss per share (vs US$0.09 loss in 3Q 2021)

Invesque Inc. to Report Q3, 2022 Results on Nov 08, 2022

Hillcrest Health Service System, Inc. acquired Two Skilled Nursing Facilities Comprised of 148 Beds in Nebraska from Invesque Inc. (TSX:IVQ) for $24.9 million.

Second quarter 2022 earnings released: US$0.17 loss per share (vs US$0.062 loss in 2Q 2021)

Centurion Asset Management Inc. and Appelt Properties Inc. acquired Healthcare Real Estate Portfolio Located in Ontario and Alberta from Invesque Inc. (TSX:IVQ) for CAD 94.6 million.

Invesque Inc. to Report Q2, 2022 Results on Aug 09, 2022

First quarter 2022 earnings released: EPS: US$0.06 (vs US$0.032 in 1Q 2021)

Invesque Inc. to Report Q1, 2022 Results on May 11, 2022

Price target decreased to US$2.20

Invesque Inc., Annual General Meeting, Jun 22, 2022

Price target decreased to US$2.20

Full year 2021 earnings: Revenues and EPS in line with analyst expectations

Invesque Inc. to Report Q4, 2021 Results on Mar 09, 2022

Third quarter 2021 earnings released: US$0.09 loss per share (vs US$1.09 loss in 3Q 2020)

Price target decreased to US$2.58

Price target decreased to US$2.69

Second quarter 2021 earnings released: US$0.06 loss per share (vs US$0.54 loss in 2Q 2020)

Shareholder Returns

Price Volatility

About the Company

Invesque Inc. Fundamentals Summary

0.0x

-0.1x

Earnings & Revenue